Part of the ICU Devices Hub — browse every related guide in one place.
Coming off ECMO is not the reverse of going on. It is a deliberate test of whether the native organ has recovered enough to take back its job, followed by a procedure — decannulation — that carries its own bleeding and vascular risks on a still-anticoagulated patient. VV and VA are weaned by different logic and different trials, and the nurse is central to running the trial, reading the response, and owning the surveillance afterward. This guide walks through readiness, how each configuration is weaned, and what happens at and after decannulation.
Before any trial, the team looks for evidence the underlying problem is reversing. On VV, that means improving native lung mechanics and gas exchange: better compliance, a clearing chest X-ray, and the ability to oxygenate and ventilate on modest ventilator settings while ECMO support is already being dialed back. On VA, it means recovering cardiac function: return of arterial pulsatility, improving contractility on echo, decreasing pressor and inotrope needs, and stable perfusion (lactate cleared, good urine output, warm extremities) at lower circuit flows. Weaning is considered when the trajectory is clearly in the right direction, not at the first flicker of improvement.
Because VV ECMO supports gas exchange, the wean tests the native lungs by removing the oxygenator's gas exchange while leaving blood flow through the circuit unchanged. The sweep gas is turned down and ultimately off (a "sweep off" or "cap" trial), so the membrane lung stops adding oxygen and removing CO2 while the pump keeps flowing. If the patient's own lungs — on their set ventilator support — maintain acceptable oxygenation and CO2 clearance over the trial period, they have demonstrated they can do the work. Note that flow is usually kept up during the trial to avoid clot from stagnant blood, even though the sweep is off. The nurse monitors saturations, blood gases, work of breathing, and hemodynamics through the trial and reports the response.
VA weaning is fundamentally different because the circuit is providing circulation. You cannot simply cap the gas — you have to hand the circulation back to the heart. So the trial gradually reduces pump flow (to a defined lower limit per protocol, not to zero, because very low flow risks clot) while the team watches with echocardiography whether the heart maintains cardiac output and perfusion. Rising pressor needs, falling blood pressure, echo evidence of poor function, or a climbing lactate at reduced flow means the heart is not ready. Because low flow increases clot risk, VA weaning trials are often kept short and anticoagulation may be adjusted. The nurse is watching the arterial waveform regain pulsatility, the perfusion markers, and the pressor requirement in real time.
| VV weaning | VA weaning | |
|---|---|---|
| Tests recovery of | Native lungs | Native heart |
| Method | Turn sweep gas down/off (flow maintained) | Reduce pump flow (to a floor, not zero) |
| Key monitoring | ABG, SpO2, work of breathing, ventilator support | Echo, MAP, pressor need, lactate, pulsatility |
| Main risk during trial | Hypoxemia/hypercarbia if lungs not ready | Low-flow clot risk; hemodynamic collapse if heart not ready |
Once a trial succeeds, the cannulas come out. This is a procedure, not a bedside afterthought. Venous cannulas are often removed with direct pressure and a period of firm compression afterward, watching for bleeding and air entrainment (the patient may be asked to hold their breath or be managed to avoid negative intrathoracic pressure at the moment of removal). Arterial cannulas, especially large surgically-placed ones, frequently require surgical repair of the vessel — you do not just pull an arterial cannula and press. On a patient who is still anticoagulated, bleeding is the dominant early risk, so anticoagulation timing around decannulation is planned.
The work does not stop when the circuit is gone. You are watching the cannulation sites for bleeding and hematoma, doing frequent distal limb perfusion checks after arterial decannulation, monitoring for venous thromboembolism (the large cannula sites are a DVT risk), watching hemodynamics and gas exchange now that the safety net is gone, and staying alert for infection at the old sites. There is also often a fluid and diuresis phase as the patient mobilizes third-spaced fluid. The first hours off ECMO are a surveillance-heavy period, not a victory lap.
Complete the set with the ECMO basics guide, the VV vs VA management guide, the circuit troubleshooting and emergencies guide, and the anticoagulation and monitoring guide. For the ventilator-liberation mindset that parallels VV weaning, see the ventilator weaning and SBT guide.
Get The ICU Notebook Newsletter
Clinical tools and career insights for ICU nurses. One email per week, no fluff.
Yes, send it freeNo spam. Unsubscribe any time.